|
Yi-Zhun Zhu, Professor
Fudan University, Pharmaceutical Sciences
Area of Focus
Drug Discovery | Pharmacology | Clinical Trials | New Drug Development | Pharmaceutical Research | Medicinal Chemistry | Biotechnology | Pharmacokinetics | Pharmacodynamics | Therapeutics |
|
Weimin Cai, Professor
Fudan University, Pharmaceutical Sciences
Area of Focus
Pharmacogenomics | Personalized Medicine | Genetic Polymorphism | Drug Metabolism | Clinical Pharmacokinetics | Pharmacodynamics | Therapeutic Drug Monitoring | End-Stage Renal Disease | Drug Resistance | Cancer Pharmacology |
|
Qingfeng He, Assistant Researcher
Fudan University, Pharmaceutical Sciences
Area of Focus
Clinical Drug Therapy | Model-Guided Precision Medicine | Model-Based Hepatotoxicity Evaluation | Pharmacokinetics | Pharmacodynamics | Pbpk Modeling | Drug Metabolism | Drug-Drug Interactions | Liver Toxicity | Quantitative Pharmacology |
|
Tang Zhijia, Assistant Researcher
Fudan University, Pharmaceutical Sciences
Area of Focus
Clinical Drug Therapy | Pharmacy Services | Pharmaceutical Administration | Diabetes | Pharmacokinetics | Pharmacodynamics | Drug Safety | Pharmacovigilance | Pharmaceutical Care | Health Quality |
|
Tang Wenlu, Associate Professor
Fudan University, Pharmaceutical Sciences
Area of Focus
Clinical Pharmacology | Evidence-Based Pharmacotherapy | Pharmacoepidemiology | Hypertension | Diabetes | Systematic Review | Meta-Analysis | Cochrane Collaboration | Drug Safety | Renin-Angiotensin System |
|
Xiang Xiaoqiang, Professor, Doctoral Supervisor
Fudan University, Pharmaceutical Sciences
Area of Focus
Quantitative Pharmacology: Pharmacokinetics | Pharmacodynamics | Modeling | Simulation | Drug Interactions | Dose Optimization | Clinical Trials | Biomarkers | Personalized Medicine | Therapeutic Drug Monitoring | Pharmacogenomics: Genetic Polymorphisms | Drug Metabolism | Gene-Drug Interactions | Genetic Testing | Pharmacokinetics |
|
Lushan Yu, Professor, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Drug Metabolism | Pharmacokinetics | Epigenetics | Transporters | Enzymes | Drug Resistance | New Drug Development | Quality Standards | Clinical Pharmacology | Non-Clinical Research |
|
Qinjie Weng, Professor, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Immunopharmacology | Autoimmune Diseases | Immune Mechanisms | Intervention Strategies | Natural Immune Regulation | Key Proteins | Potential Treatments | Drug Safety | Toxicology | Innovative Drugs |
|
Jiajia Wang, Distinguished Researcher | Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Neuropharmacology: Multiple Sclerosis | Stroke | Spinal Cord Injury | Peripheral Nerve Injury | Demyelination | Pathogenesis | Intervention Strategies | Neurotoxicity | Immune Cells | Autoimmunity | Immunopharmacology: Macrophages | Dendritic Cells | Autoimmune Diseases | Immunotoxicity | Drug Targets | Molecular Mechanisms | Therapeutic Strategies | Neuro/Immunotoxicology: Clinical Drugs | Research | Clinical Studies | Drug Safety | Toxicology | Pharmacology |
|
Danyan Zhu, Associate Professor, Master's Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Cardiovascular Pharmacology: Heart | Blood Vessels | Drugs | Pharmacodynamics | Pharmacokinetics | Cardiovascular Diseases | Therapeutic Agents | Toxicology | Clinical Trials | Molecular Mechanisms | Stem Cell Biology: Stem Cells | Differentiation | Regeneration | Cell Therapy | Embryonic Stem Cells | Adult Stem Cells | Pluripotency | Cell Signaling | Tissue Engineering | Gene Expression | Drug Toxicology: Toxicology | Drug Safety | Adverse Effects | Pharmacovigilance | Toxicokinetics | Risk Assessment | Biomarkers | In Vitro Models | In Vivo Models | Regulatory Toxicology |
